Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-12-003441

Options or other derivatives

  • Director acquired 36,458 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FORBES CHRISTOPHER · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-02-16 Grant or award : show line 1 in the form Common Stock Option +36,458 $0.26 2017-02-16 36,458 1,015,197 D
Loading xslF345X03/edgar.xml…